| Date Filed | Type | Description |
| 08/17/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/23/2022 |
3
| Dickey Robert IV (CFO) has filed a Form 3 on Enveric Biosciences, Inc. |
| 04/04/2022 |
3
| Dickey Robert IV (CFO) has filed a Form 3 on AIM ImmunoTech Inc. |
| 02/16/2022 |
5
| Dickey Robert IV (Director) has filed a Form 5 on AngioGenex, Inc. |
| 07/13/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/30/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/28/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/02/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/01/2014 |
4
| Dickey Robert IV (CFO) has filed a Form 4 on NeoStem, Inc.|
Txns:
| Granted 6,303 shares
@ $0
Granted 25,000 options to buy
@ $6.21, valued at
$155.3k
|
|
| 07/01/2014 |
4
| Dickey Robert IV (CFO) has filed a Form 4 on NeoStem, Inc.|
Txns:
| Granted 279 shares
@ $5.542, valued at
$1.5k
|
|
| 01/03/2014 |
4
| Dickey Robert IV (CFO) has filed a Form 4 on NeoStem, Inc.|
Txns:
| Granted 35,000 options to buy
@ $7.77, valued at
$272k
|
|
| 08/20/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/20/2013 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 06/07/2012 |
4
| Dickey Robert IV (Senior Vice President) has filed a Form 4 on HEMISPHERX BIOPHARMA INC|
Txns:
| Acquired 50,000 options to buy
@ $0.29, valued at
$14.5k
|
|
| 12/08/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/22/2009 |
3
| Form 3 -- Initial statement of beneficial ownership of securities |